Xylem on Tuesday raised its annual sales and profit forecasts, banking on resilient demand for its water treatment equipment, while also beating Wall Street estimates for third-quarter results.

Discover Xylem Inc.'s Q3 2025 earnings highlights, raised guidance, and margin expansion strategy. See how portfolio moves drive growth.

Duolingo is saying no, non, nein, and nyet to San Francisco. The language learning app is headquartered in Pittsburgh, which isn’t exactly known as a booming hub of startups and venture capital. But ...

The third-party app store known as AltStore, one of the first companies to offer an alternative app marketplace in the European Union, is preparing to connect its platform with the open social web ...

Language-learning app Duolingo has cast Duo — its adorable and plucky owl mascot — as the star of the company’s first-ever anime series, “最後の決戦 (The Final Test).” The company produced the five-episode ...

Duolingo is turning its famous, or infamous, depending on your academic proclivities, green owl mascot into an animated hero. The language-learning app has announced The Final Test, a five-episode, ...

A new RNA biotech has risen with a $200 million series A in the tank and a team of seasoned biotech chefs ready to light the burners. Soufflé Therapeutics will cook up siRNA medicines that are ...

Construction of a new $95 million Coriell Institute Strategic Innovation Center is underway in Camden. The building is expected to open in early 2028. The location, which was announced in February, ...

NEW DELHI: Coursera, a global online learning platform, has announced its inclusion as one of OpenAI’s first generation of apps integrated into ChatGPT, unveiled at OpenAI’s DevDay. This marks the ...

Actor-filmmaker Basil Joseph’s maiden production under his newly launched banner Basil Joseph Entertainment is set to take a key step forward this week. The title teaser of the company’s debut film, ...

After axing a wide swath of federal research projects and grants, a recent slew of awards offers a glimpse into the kinds of science the second Trump administration wants to back: in vivo cell ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Geoff Weiss Every time Geoff publishes a story, you’ll get an alert straight to your inbox!